- Home
- SKM vs RVMD Comparison
SKM vs RVMD Comparison
Compare SKM & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKM
- RVMD
- Stock Information
- Founded
- SKM 1984
- RVMD 2014
- Country
- SKM South Korea
- RVMD United States
- Employees
- SKM N/A
- RVMD N/A
- Industry
- SKM Telecommunications Equipment
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SKM Telecommunications
- RVMD Health Care
- Exchange
- SKM Nasdaq
- RVMD Nasdaq
- Market Cap
- SKM 8.7B
- RVMD 8.7B
- IPO Year
- SKM 1996
- RVMD 2020
- Fundamental
- Price
- SKM $22.68
- RVMD $41.33
- Analyst Decision
- SKM
- RVMD Strong Buy
- Analyst Count
- SKM 0
- RVMD 13
- Target Price
- SKM N/A
- RVMD $65.15
- AVG Volume (30 Days)
- SKM 197.2K
- RVMD 1.2M
- Earning Date
- SKM 02-12-2025
- RVMD 02-26-2025
- Dividend Yield
- SKM 4.42%
- RVMD N/A
- EPS Growth
- SKM 21.68
- RVMD N/A
- EPS
- SKM 4.08
- RVMD N/A
- Revenue
- SKM $12,144,584,180.00
- RVMD $742,000.00
- Revenue This Year
- SKM $2.84
- RVMD N/A
- Revenue Next Year
- SKM $1.71
- RVMD $1,855.56
- P/E Ratio
- SKM $9.81
- RVMD N/A
- Revenue Growth
- SKM 1.89
- RVMD N/A
- 52 Week Low
- SKM $19.88
- RVMD $28.95
- 52 Week High
- SKM $24.58
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- SKM 64.48
- RVMD 44.66
- Support Level
- SKM $21.69
- RVMD $40.13
- Resistance Level
- SKM $23.07
- RVMD $42.68
- Average True Range (ATR)
- SKM 0.25
- RVMD 1.41
- MACD
- SKM 0.17
- RVMD 0.10
- Stochastic Oscillator
- SKM 80.50
- RVMD 26.42
About SKM SK Telecom Co. Ltd.
SK Telecom is South Korea's largest wireless telecom operator, with 31 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 6.9 million broadband customers and 9.5 million pay TV customers (6.8 million IPTV and 2.7 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.